Inventor
NARA SUSHEEL JETHANAND
IN28 patents
⚠️ This page may combine multiple inventors who share the name “NARA SUSHEEL JETHANAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
27 patentsUS9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US10959986B2Mar 30, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations72
US10399933B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations72
US10253027B2Apr 9, 2019
Aryl lactam kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US9708337B2Jul 18, 2017
Aryl amide-based kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US10399932B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US11713312B2Aug 1, 2023
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US11254663B2Feb 22, 2022
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US11337970B2May 24, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations62
US10544120B2Jan 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US12145927B2Nov 19, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US12269819B2Apr 8, 2025
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO0 citations51
US12059420B2Aug 13, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO0 citations51
US9932320B2Apr 3, 2018
Quinoline-based kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US8969564B2Mar 3, 2015
Aryl ether-base kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US8901305B2Dec 2, 2014
Aryl lactam kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US8703953B2Apr 22, 2014
Aryl ether-base kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US12319676B2Jun 3, 2025
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations48
US12286424B2Apr 29, 2025
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO0 citations47
US12030835B2Jul 9, 2024
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations47
US12227496B2Feb 18, 2025
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations46
US10035777B2Jul 31, 2018
Heterocyclic kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US10730863B2Aug 4, 2020
Bridged bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations38
US10174044B2Jan 8, 2019
Fused pyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations37